A Study to Test Whether Avenciguat Helps People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) Who Had Bleeding in the Esophagus or Fluid Accumulation in the Belly

NCT06082843 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

22

Enrollment

INDUSTRY

Sponsor class

Stopped Company decision

Conditions

Hypertension, Portal
Liver Cirrhosis

Interventions

DRUG: Placebo
DRUG: Avenciguat

Sponsor

Boehringer Ingelheim